Wall Street: Nvidia und Johnson & Johnson stehen zum Auftakt im Fokus Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…
Johnson & Johnson (JNJ) Reports Q2 Earnings: What Key Metrics Have to Say The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended June…
Johnson & Johnson Aktie: Zölle wohl doch nicht so schlimm Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…
Geschäfte mit Medizintechnik treibt Johnson & Johnson an - Prognosen angehoben NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) blickt nach einem überraschend guten zweiten Quartal zuversichtlicher auf das…
Stocks making the biggest moves premarket: Goldman Sachs, ASML, Diageo, Johnson & Johnson and more These are the stocks posting the largest moves in premarket trading.…
Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales Johnson & Johnson reported second-quarter profit and raised its full-year sales forecast by around $2 billion on Wednesday as strong…
Johnson & Johnson delivers earnings beat, raises full year sales and profit guidance Johnson & Johnson (NYSE:JNJ) shares edged higher premarket as the healthcare firm reported an earnings beat for the second quarter…
Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock. Key PointsKenvue is spending big to drum up demand for its diversified product portfolio.The companys weak results reflect pressure on…
Should You Buy Johnson & Johnson Stock Before July 16th? Key PointsJohnson & Johnson reports earnings on Wednesday.Investors may be paying attention to tariff-related developments more so than the companys…
Andrew Hill Dumps 38,000 Johnson & Johnson Shares in Q2 2025 Exit Key PointsThe investment advisor sold 38,037 shares for a total of $6.31 million in Q2 2025.Move removes JNJ from portfolio,…
This Stock Has Increased 4,720%: Heres Why Its Still a Buy Key PointsJohnson & Johnson has delivered excellent returns to its long-term shareholders. One key factor behind the companys success is…
Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Should You Buy? Johnson & Johnson (JNJ) possesses the right combination of the two key ingredients for a likely earnings beat in its…
Heres Why Johnson & Johnson (JNJ) is a Strong Momentum Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…
Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Dividend Stock Instead? Key PointsJohnson & Johnson is a Dividend King.The stock offers an attractive 3.4% dividend yield.Another healthcare stock has a 7.4%…
Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…
Johnson & Johnson (JNJ) Could Be a Great Choice Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now? Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
Top Analyst Reports for Johnson & Johnson, Home Depot and Micron MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.…
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts Johnson & Johnson (JNJ) concluded the recent trading session at $155.92, signifying a +2.08% move from its prior days close.…
Zacks Investment Ideas feature highlights: Jabil, Apple, Amazon, Johnson & Johnson and Ericsson Detailed price information for Jabil Circuit (JBL-N) from The Globe and Mail including charting and trades.…